Last reviewed · How we verify
NCT05232188
Effect of Renal Access Sheath on Functions
NA trial testing Percutaneous nephrolithotomy in Kidney Function Tests in 88 participants. Status unknown.
1 December 2022
Quick facts
| Lead sponsor | Bakirkoy Dr. Sadi Konuk Research and Training Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 88 |
| Start date | 1 December 2020 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Percutaneous nephrolithotomy
Conditions studied
- Kidney Function Tests — all drugs for Kidney Function Tests →
- Treatment Outcome — all drugs for Treatment Outcome →
Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Who can join
Adults 18 to 65, any sex, with Kidney Function Tests or Treatment Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients will be randomly divided into two groups in order to evaluate the effect of the size of the access sheath (Amplatz) used in the Percutaneous Nephrolithotomy (PCNL) operation on kidney functions. After dilatation, 22French (Fr) Amplatz sheath will be placed in the first group, while 28Fr Amplatz sheath will be placed in the second group. The functional difference will be evaluated with preoperative and postoperative 3rd-month kidney scintigraphies (diethylenetriamine pentaacetic acid (DTPA) and technetium-99m dimercaptosuccinic acid (DMSA). In addition, Kidney Injury Molecule-1 (KIM-1) levels will be measured in the urine in order to be a predictor of functional loss in the early period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05232188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous nephrolithotomy
Trials testing the same drug.
- NCT07322471 — Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones · NA · not yet recruiting
- NCT04943081 — Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease · NA · unknown
- NCT05077007 — Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers · NA · unknown
Other Bakirkoy Dr. Sadi Konuk Research and Training Hospital trials
Trials by the same sponsor.
- NCT07425379 — Prehabilitation in Breast Cancer Surgery · NA · not yet recruiting
- NCT07367321 — Comparison of Onlay Mesh Repair and Sublay Mesh Repair in Umbilical Hernia Surgery · NA · not yet recruiting
- NCT07077629 — Geriatric Patients Undergoing Gynaecological Cancer Surgery · completed
- NCT07000461 — Transcranial Doppler as a Predictor of Postoperative Cognitive Dysfunction Following Cardiopulmonary Bypass · recruiting
- NCT07295405 — Water Temperature and Bowel Cleansing Quality · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05232188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Last refreshed: 13 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05232188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing